Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Oct 17;283(6298):1021–1023. doi: 10.1136/bmj.283.6298.1021

Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.

A Balducci, G Slama, J Rottembourg, A Baumelou, A Delage
PMCID: PMC1507244  PMID: 6794746

Abstract

The kinetics of absorption of intraperitoneally administered insulin were studied in nine uraemic insulin-dependent diabetics undergoing continuous ambulatory peritoneal dialysis (CAPD). In each of three studies 20 U of regular insulin was directly injected as a bolus into the peritoneal cavity through an indwelling Tenckhoff catheter. In two procedures the insulin injection was followed by the instillation of either 2 litres of 1.5% dextrose dialysates or 2 litres of 4.5% dextrose dialysate. In the third 20 ml of saline was used to flush the tubing. Plasma free insulin values rose more rapidly and reached significantly higher concentrations (55.6 +/- 18.8 mU/l) when the insulin had been injected into an empty peritoneal cavity than when it was followed by dialysate. These differences were observed despite the fact that most of the insulin injected was retained by the patients. Since the plasma insulin values did not differ after instillations of dialysate containing 1.5% and 4.5% dextrose, the osmolality of the dialysate seemed not to affect insulin absorption, and the dilution of the insulin probably delayed its transfer through the peritoneum. These findings suggest that insulin given intraperitoneally to patients undergoing CAPD will be most effective if it is given into an empty peritoneal cavity at least 30 minutes before the dialysate is instilled.

Full text

PDF
1021

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumenkrantz M. J., Shapiro D. J., Mimura N., Greopoulus D. G., Griedler R. M., Levin S., Tenckhoff H., Coburn J. W. Maintenance peritoneal dialysis as an alternative in the patient with diabetes mellitus and end-stage uremia. Kidney Int Suppl. 1974 Oct;(1):108–114. [PubMed] [Google Scholar]
  2. Boyer J., Gill G. N., Epstein F. H. Hyperglycemia and hyperosmolality complicating peritoneal dialysis. Ann Intern Med. 1967 Sep;67(3):568–572. doi: 10.7326/0003-4819-67-3-568. [DOI] [PubMed] [Google Scholar]
  3. Crossley K., Kjellstrand C. M. Intraperitoneal insulin for control of blood sugar in diabetic patients during peritoneal dialysis. Br Med J. 1971 Jan 30;1(5743):269–270. doi: 10.1136/bmj.1.5743.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Flynn C. T., Nanson J. A. Intraperitoneal insulin with CAPD - an artificial pancreas. Trans Am Soc Artif Intern Organs. 1979;25:114–117. doi: 10.1097/00002480-197902500-00023. [DOI] [PubMed] [Google Scholar]
  5. Greenwood R. H., Davies C. J., Senator G. B., O'Brien I., Hayes T. M. Intraperitoneal insulin in diabetes. Lancet. 1979 Aug 11;2(8137):312–312. doi: 10.1016/s0140-6736(79)90334-9. [DOI] [PubMed] [Google Scholar]
  6. Nakagawa S., Nakayama H., Sasaki T., Yoshino K., Yu Y. Y. A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes. 1973 Aug;22(8):590–600. doi: 10.2337/diab.22.8.590. [DOI] [PubMed] [Google Scholar]
  7. Popovich R. P., Moncrief J. W., Nolph K. D., Ghods A. J., Twardowski Z. J., Pyle W. K. Continuous ambulatory peritoneal dialysis. Ann Intern Med. 1978 Apr;88(4):449–456. doi: 10.7326/0003-4819-88-4-449. [DOI] [PubMed] [Google Scholar]
  8. Poulsen J. S., Smith M., Deckert M., Deckert T. Comparison of intraperitoneal, intraportal and intravenous insulin infusion. Acta Endocrinol (Copenh) 1980 Dec;95(4):500–504. doi: 10.1530/acta.0.0950500. [DOI] [PubMed] [Google Scholar]
  9. Quelhorst E., Schuenemann B., Mietzsch G., Jacob I. Haemo- and peritoneal dialysis treatment of patients with diabetic nephropathy--a comparative study. Proc Eur Dial Transplant Assoc. 1978;15:205–212. [PubMed] [Google Scholar]
  10. Rubin J., Oreopoulos D. G., Blair R. D., Chisholm L. D., Meema H. E., deVeber G. A. Chronic peritoneal dialysis in the management of diabetics with terminal renal failure. Nephron. 1977;19(5):265–270. doi: 10.1159/000180899. [DOI] [PubMed] [Google Scholar]
  11. Schade D. S., Eaton R. P., Friedman N., Spencer W. The intravenous, intraperitoneal, and subcutaneous routes of insulin delivery in diabetic man. Diabetes. 1979 Dec;28(12):1069–1072. doi: 10.2337/diab.28.12.1069. [DOI] [PubMed] [Google Scholar]
  12. Schade D. S., Eaton R. P., Spencer W., Goldman R., Corbett W. T. The peritoneal absorption of insulin in diabetic man: a potential site for a mechanical insulin delivery system. Metabolism. 1979 Mar;28(3):195–197. doi: 10.1016/0026-0495(79)90064-7. [DOI] [PubMed] [Google Scholar]
  13. Shapiro D. J., Blumenkrantz M. J., Levin S. R., Coburn J. W. Absorption and action of insulin added to peritoneal dialysate in dogs. Nephron. 1979;23(4):174–180. doi: 10.1159/000181630. [DOI] [PubMed] [Google Scholar]
  14. Slama G., Buu K. N., Tchobroutsky G., Delage A., Desplanque N. Plasma insulin and C-peptide levels during continuous subcutaneous insulin infusion. Diabetes Care. 1979 May-Jun;2(3):251–255. doi: 10.2337/diacare.2.3.251. [DOI] [PubMed] [Google Scholar]
  15. Slama G., Klein J. C., Delage A., Rottembourg J., Marouani A., Jacobs C. The use of the artificial pancreas in uremic diabetic patients. Horm Metab Res Suppl. 1979;(8):178–183. [PubMed] [Google Scholar]
  16. Tenckhoff H., Schechter H. A bacteriologically safe peritoneal access device. Trans Am Soc Artif Intern Organs. 1968;14:181–187. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES